Bluejay Diagnostics, Inc. (BJDX) financial statements (2022 and earlier)

Company profile

Business Address 360 MASSACHUSETTS AVENUE, SUITE 203
ACTON, MA 01720
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,048
Cash and cash equivalents19,048
Prepaid expense160
Other undisclosed current assets1,452
Total current assets:20,660
Noncurrent Assets
Property, plant and equipment337
Other noncurrent assets21
Total noncurrent assets:358
TOTAL ASSETS:21,019
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:339
Accounts payable296
Accrued liabilities339
Employee-related liabilities158
Other undisclosed accounts payable and accrued liabilities(454)
Debt5
Due to related parties2
Total current liabilities:346
Noncurrent Liabilities
Other undisclosed liabilities291
Total liabilities:637
Stockholders' equity
Stockholders' equity attributable to parent20,382
Common stock2
Additional paid in capital28,074
Accumulated deficit(7,695)
Total stockholders' equity:20,382
TOTAL LIABILITIES AND EQUITY:21,019

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues
(Other Income)
20
Gross profit:20
Operating expenses(3,230)
Other undisclosed operating loss(20)
Operating loss:(3,230)
Nonoperating expense(258)
Interest and debt expense(9)
Loss before gain (loss) on sale of properties:(3,497)
Other undisclosed net income9
Net loss available to common stockholders, diluted:(3,488)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(3,488)
Comprehensive loss, net of tax, attributable to parent:(3,488)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: